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AktHigh-altitude residents have lowermortality rates for ischaemic heart disease and this is ascribed to cardiac gene
remodelling by chronic hypoxia. SUR2A is a cardioprotective ABC protein serving as a subunit of sarcolemmal
ATP-sensitive K+ channels. The purpose of this study was to determine whether SUR2A is regulated by mild
hypoxia in vivo and to elucidate the underlying mechanism. Mice were exposed to either 21% (control) or 18%
(mild hypoxia) oxygen for 24 h. Exposure to 18% oxygen did not affect partial pressure of O2 (PO2) and CO2
(PCO2) in the blood, haematocrit or level of ATP in the heart. However, hypoxia increased myocardial lactate
dehydrogenase (LDH) and lactate as well as NAD+ without affecting total NAD. SUR2A levels were signiﬁcantly
increased as well as myocardial resistance to ischaemia–reperfusion. Exposure to 18% oxygen did not phosphor-
ylate extracellular signal regulated kinases (ERK1/2) or AMP activated protein kinase (AMPK), but it phosphor-
ylated protein kinase B (Akt). An inhibitor of phosphoinositide 3-kinases (PI3K), LY294002 (0.2 mg/mouse),
abolished all observed effects of hypoxia. LDH inhibitors, galloﬂavin (50 μM) and sodium oxamate (80 mM)
signiﬁcantly decreased levels of SUR2A in heart embryonic H9c2 cells, while inactive mutant LDH form,
gly193-M-LDH increased cellular sensitivity towards stress induced by 2,4-dinitrophenol (10 mM). Treatment
of H9c2 cells with sodium lactate (30 mM) increased intracellular lactate, but did not affect LDH activity or
SUR2A levels. We conclude that PI3K/Akt signalling pathway and LDH play a crucial role in increase of cardiac
SUR2A induced by in vivo exposure to 18% oxygen.
© 2015 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
SUR2A is an “atypical” ABC protein that binds to inward rectiﬁer
Kir6.2 to form ATP-sensitive K+ (KATP) channels in the sarcolemma
[1]. Increase in level of SUR2A is associated with increased myocardial
resistance to metabolic stress in both healthy and diseased hearts
[2–4]. A SUR2A-mediated increase in myocardial resistance to stress
increases physical endurance, decreases size of myocardial infarction
induced by ischaemia–reperfusion and counteracts ageing-induced de-
cline in physical performance [2–5]. Themechanismof cardioprotection
afforded by SUR2A is still under investigation. SUR2A is the least
expressed KATP channel-forming protein and its levels seems to be a
rate limiting factor in KATP channel formation [2,6]. It has been reported
that increased expression of SUR2A results in increased numbers of fully
assembled KATP channels resulting in their earlier activation when the
heart is exposed to ischemia. In turn, this shortens action membrane
potential and prevents inﬂux of Ca2+ and Ca2+ overload, which is
cardioprotective [2]. However, there aremore recent studies suggesting
that cardioprotection afforded by KATP channels could be alsomediated,44 1382 383 598.
ić).
. This is an open access article underat least in part, independently from the channel opening [7–9]. It has
been proposed that sarcolemmal KATP channel protein complex controls
subsarcolemmal levels of ATP by activity-independent mechanism,
which promotes cardioprotection during stress conditions [7–9].
Manipulation with SUR2A levels has been suggested to be a promising
therapeutic strategy against ischaemic heart diseases and other diseases
where increased heart resistance to stress is beneﬁcial [10–12].
Some years ago, it has been reported that high-altitude residents have
lower mortality rates for ischaemic heart disease [13–15] and this
has been conﬁrmed by later studies [16]. In agreement with such
studies were also ﬁndings that exposure to moderate hypoxia confers
cardioprotection in experimental animals in vivo [17,18]. As SUR2A
is an important factor in regulating heart resistance to metabolic
stress we thought that it is worthwhile to assess whether mild hypoxia
in vivo regulates cardiac levels of this protein. If it does, it could positively
modify the outcome of a range of cardiovascular diseases, which is what
was observed in clinical and experimental studies [13–18].
Therefore, in this study we have tested whether exposure to mild
hypoxia (18% oxygen), which is equivalent to oxygen tension occurring
at ~1200mabove sea level, would have any effect on SUR2A expression.
Not only did we ﬁnd that this concentration of oxygen increases level
of SUR2A, but that it does that by activating a previously unknown
signalling cascade.the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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2.1. Mice and in vivo exposure to hypoxia
C57BL/6J male mice (6–8 weeks old) were exposed to either ambi-
ent oxygen (detected to be 21%) or fractional concentration of oxygen
of 18% oxygen (normobaric) using integral Animal Hypoxia Chamber
System; oxygen levels were controlled by ProOx Model 110 version
2.2 (Biospherix, Lacona, NY, USA). Mice, in groups of 5, were placed in
a plexiglass chamber for 24 h in either 21% or 18% oxygen, which level
was continuously monitored. All manipulations with animals including
heart harvesting were performed inside the chamber. For hearts
harvestingmicewere sacriﬁced using a schedule 1 procedure of cervical
dislocation. Some animals were injected i.p. with inhibitor of phos-
phatidylinositol 3-kinases (PI3K), LY294002 (0.2 mg/mouse; volume
was 200 μl and vehicle was saline; Sigma-Aldrich, Gillingham, UK). For
this series of experiments, control animalswere injectedwith only vehi-
cle (ie. 200 μl of saline i.p. injection) and subjected to the same protocol
as LY294002-treated animals. All experiments have been approved
by the appropriate ethical committee in agreement with the 1964
Declaration of Helsinki and its later amendments and the UK Home
Ofﬁce. The experiments have been done under authority of Project
Licences 60/3925 and 70/7796.2.2. H9c2 cells
Some experiments were performed on rat embryonic heart-derived
female H9c2 cells (ECACC, Salisbury, UK). Cells were cultured in a tissue
ﬂask containing DMEM medium and were supplemented with 2 mM
glutamine and 10% FCS in a 96-well plate. The cells were stored at 37 °C
at 5% CO2. Either galloﬂavine (50 μM; Tocris Bioscience, Bristol, UK),
sodium oxamate (80 mM; Sigma Aldrich, Gillingham, UK) or sodium
lactate (30mM; Sigma Aldrich, Gillingham, UK)was added into the cul-
ture media and solvent was added to the control group. The cultures
were then left for a 24 hour incubation period before experimentation.
For the experiments with inactive mutant of muscle form of LDH
(gly193-M-LDH) H9C2 cells were infected with adenoviral constructs
containing either luciferase (cells infected with luciferase have served as
control cells in this study) or gly193-M-LDH. To infect H9C2 cells, a solu-
tion of recombinant adenovirus was mixed with culture medium, and
cells were exposed to the virus with a multiplicity of 10 viral particles/
cell for 48 h. Experiments were performed 48 h after the infection.2.3. Cell survival assay
The survival of H9C2 cells were assayed usingMultitox-Fluor Multi-
plex Cytotoxicity Assay (Promega). Brieﬂy, H9C2 cells were plated in
complete media (DMEM containing 10% FCS) in a 96-well plate, the
recombinant adenovirus (luciferase or gly193-M-LDH) was added to
the wells. After 48 h infection, the DNP was added to each well at the
ﬁnal concentration of 10mM. Tomeasure cell survival 6 h later, the pep-
tide substrate (GF-AFC) that can be cleaved only by live cells was added
to the eachwell. Following 30min-long incubation at 37 °C, plates were
measured using 1420Multibabel Counter (Victor) plate reader, with ex-
citation at 370 nm and emissions of 480 nm. The percentage of live cells
was calculated based on the intensity of ﬂuorescence according to the
manufacturer's instructions.Fig. 1. Western blot signals obtained by anti-AMPK antibodies were of appropriate
molecular weight and clearly distinguishable from any other signals appearing on blots.
Typical examples of original Western blots in this study when using anti-AMPK (AMPK)
and anti-phospho-AMPK (P-AMPK) antibodies.2.4. Blood gas and haematocrit analysis
Blood gas (PO2 and PCO2) and haematocrit were measured in sam-
ples (500–700 μl) taken directly from the heart using pre-heparinised
(1000 IU/ml) syringes and Rapidlab 348EX blood Gas System (Siemens,
Frimley, UK).2.5. Western blotting
For Western blotting hearts/H9c2 cells were harvested and snap-
frozen and homogenised in lysis buffer (50 mM Tris–HCl, pH 7.5;
1 mM EDTA; 1 mM EGTA; 1% (w/v) Triton X-100; 0.1% (v/v)
mercaptoethanol; 1 mM sodium orthovanadate; 50 mM sodium
ﬂuoride; 5 mM sodium pyrophosphate; 1 μMmicrocystin-LR; and one
tablet of “complete” proteinase inhibitor per 50 ml of buffer). A
10-fold mass excess of ice-cold lysis buffer was added to the powdered
tissue, brieﬂy vortexed, and then centrifuged at 4 °C for 10 min at
13,000 g to remove insoluble material. The supernatant was snap-
frozen in aliquots in liquid nitrogen and stored at−80 °C. Protein concen-
tration was determined by Bradford Assay. From each sample, 20 μg of
protein was subjected to SDS/PAGE and transferred to nitrocellulose.
For all blots, the nitrocellulose membranes were incubated at 4 °C for
16 h using the antibodies against SUR2A, Kir6.2 (both from Santa Cruz
Biotechnology, Heidelberg, Germany), Akt, AMPK, ERK1/2, phospho-Akt
antibodies (Thr308 and Ser473), phosphor-AMPK and phospho-ERK1/2
(all from Millipore, Watford, UK). All antibodies were applied in 1:1000
dilution. The blots were incubated in 50 mM Tris/HCl, pH 7.5; 0.15 M
NaCl; and 0.2% (by vol) Tween containing 5% (by mass) skimmed
milk. Detection of total or phosphorylated protein was performed using
horse radish peroxidase conjugated secondary antibodies (Pierce,
Rockford, IL, USA) and enhanced chemiluminescence (ECL) reagent
(Upstate, Dundee, UK). All antibodies apart from anti-AMPK and anti-
phospho-AMPK have been characterised in detail and this characterisa-
tion has been published in our recent paper [18]. Thus, SUR2A antibody
produced a single signal in the expected region, while Kir6.2 antibody
produced several signals, but one of those was the exact size of
this protein. Antibodies against ERK1/2, phospho-ERK1/2, Akt, S473
phospho-Akt, T308 phospho-Akt, AMPK and phospho-AMPK yielded
solitary or double signals (where appropriate) in expected regions (see
ref. [19]; Fig. 1). The band intensities were analysed using Quantiscan
software (Cambridge, UK).2.6. Measurement of ATP
ATP concentration in heart tissue was measured using luciferase-
based ATP determination kit (Invitrogen, Paisley, UK) according to the
manufacturer's instructions. Luminescence was measured at 560 nm
using microplate reader/multidetection reader (SPECTRAMAX M2,
Molecular Devices, Wokingham, UK).
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NAD/NADH was measured in heart tissue using NAD/NADH kit
(Abcam, Cambridge, UK) according to the manufacturer's instruction.
Absorbance was measured at 450 nm using microplate reader/
multidetection reader (SPECTRAMAX M2, Molecular Devices,
Wokingham,UK). Total NAD (NADt) andNADHwere estimated directly
while the value of NAD+ was estimated by subtracting NADH from
NADt.
2.8. Measurement of lactate and LDH in the heart
Lactate was measured in heart tissue lysates using ADVIA Chemistry
Lactate Enzymatic Assay and ADVIA Chemistry System 1200 (Siemens,
Frimley, UK). Lactate is oxidised by lactate oxidase to pyruvate and
hydrogen peroxide and it was measured by the formation of dye from
hydrogen peroxide and a chromogen in the presence of a peroxidase.
Absorbance was measured at 545/694 nm. LDH was measured using
ADVIA Chemistry System 2400 (Siemens, Frimley, UK). Lactate
dehydrogenase catalyses the conversion of lactate to pyruvate in the
presence of NAD. The enzymatic activity of lactate dehydrogenase is
proportional to the rate of production of NADH. The amount of NADH
produced is determined by increase in absorbance at 340/410 nm.
2.9. Ischaemia–reperfusion and measurement of size of myocardial
infarction, creatine kinase (CK) and LDH
The heart collection and ischaemia–reperfusion injury was per-
formed as described in detail in our previous papers [3,19]. In brief,
mice were killed by cervical dislocation (according to UK Home Ofﬁce
procedures), the hearts rapidly removed, the aorta cannulated, secured
and attached to a custom-made Langendorff perfusion apparatus.
Hearts were perfused at a constant ﬂow rate of 5 ml/min at 37 °C with
oxygenated (95% O2, 5% CO2; the PO2 in perfusate was ~600 mm Hg)
Tyrode's solution (in mM: NaCl 136.5, KCl 5.4, CaCl2 1.8, MgCl2 0.53,
glucose (Glc) 5.5, HEPES-NaOH 5.5, pH 7.4) for a stabilisation period of
30min. The heart was then subjected to 30min of ischaemia by placing
it into degassed Tyrode's (the solution was degassed with argon for
60 min and the PO2 in this solution was ~20 mm Hg) and switching
off perfusion. A second60minute reperfusionwith oxygenated Tyrode's
followed the ischaemia. In some experiments during this period efﬂuent
was collected for later measurement of CK and LDH. CK and LDH in ef-
ﬂuent were measured using ADVIA Chemistry System 2400 (Siemens,
Frimley, UK). LDHwasmeasured as described in above section. CKmea-
surement was based on reaction with creatine phosphate and ADP,
which form ATP coupled to the hexokinase–G6PD reaction, generating
NADPH. The concentration of NADPH as a measure of CK activity was
determined by changes in absorbance at 340/410 nm. After reperfusion,
some hearts were snap-frozen in liquid nitrogen and stored at−80 °C.
Infarct size was determined using triphenyltetrazolium chloride (TTC)
as described previously [3].
2.10. Statistical analysis
Data are presented as mean± S.E.M., with n representing the num-
ber of analysed mice. Mean values were compared by Student's t-test
using SigmaStat program (Jandel Scientiﬁc, Chicago, Illinois). P b 0.05
was considered statistically signiﬁcant.
3. Results
3.1. 24 h-long exposure to 18% oxygen up-regulates SUR2A in the heart
Mice were exposed to either atmospheric oxygen that was
measured to be 21% or to 18% oxygen. Oxygen tension in the blood
was decreased in mice exposed to 18% oxygen, but the difference wasnot statistically signiﬁcant (PO2 in the blood was 37.8 ± 5.8 mm Hg in
mice exposed to 21% oxygen and 26.0 ± 6.1 mm Hg in mice exposed
to 18% oxygen, n = 5 for each, P = 0.211; Fig. 2). No differences were
observed between blood levels of CO2 (PCO2 in the blood was 33.7 ±
6.2 mm Hg in mice exposed to 21% oxygen and 32.9 ± 2.7 mm Hg in
mice exposed to 18% oxygen, n = 5 for each, P = 0.753; Fig. 2) and
haematocrit did not differ between experimental groups (haematocrit
was 39.0 ± 3.0% in mice exposed to 21% oxygen and 39.0 ± 0% in
mice exposed to 18% oxygen, n = 5 for each, P = 1.000; Fig. 2). The
level of ATP in heart tissue was not affected (5.8 ± 0.9 nmol/l in mice
exposed to 21% oxygen and 5.8 ± 1.5 nmol/l in mice exposed to 18%
oxygen, n= 5 for each, P= 0.983; n= 5 for each; Fig. 2), but exposure
to 18% oxygen signiﬁcantly increased lactate levels in the heart (from
0.16 ± 0.02 mmol/l to 0.33 ± 0.05 mmol/l, P = 0.013, n = 5; Fig. 2).
An increased level of lactate was accompanied by increased level of
LDH (from 817.6 ± 117.0 U/l to 1477.2 ± 112.7, n = 5, P b 0.01;
Fig. 2). In addition to that, exposure to 18% oxygen was associated
with signiﬁcant decrease in myocardial NADH (24.5 ± 0.6 nmol/l vs
15.1 ± 2.8 nmol/l, P = 0.030, n = 3–4; Fig. 2) and increase in NAD+
(0.1 ± 0.05 nmol/l vs 7.6 ± 2.4 nmol/l, P = 0.045; Fig. 2). Total NAD
was not affected (23.9 ± 0.1 nml/l vs 24.0 ± 0.2 nmol/l, P = 0.755,
n= 3-4; Fig. 2). At the same time, exposure to 18% oxygen dramatically
increased level of SUR2A (Fig. 2; signal intensity was 22.7 ± 10.1 AU in
mice exposed to 21% oxygen and 224.9 ± 18.6 AU in mice exposed to
18% oxygen, n = 4, P b 0.001), while the levels of Kir6.2 were just
slightly, but signiﬁcantly, increased (signal intensity was 53.8 ±
1.9 AU in mice exposed to 21% oxygen and 64.0 ± 1.1 AU in mice
exposed to 18% oxygen, n = 3, P = 0.006; data not shown). We have
tested whether exposure to 18% oxygen would affect myocardial resis-
tance to ischaemia–reperfusion by measuring the size of myocardial
infarction as well as amounts of CK and LDH released from the muscle
during this challenge. We have found that exposure to 18% oxygen sig-
niﬁcantly decreased the size of myocardial infarction (from 32.4± 1.9%
in mice exposed to 21% oxygen to 22.7 ± 1.8% in mice exposed to 18%
oxygen, n = 3, P = 0.044) and hearts from animals exposed to 18%
oxygen released signiﬁcantly less CK and LDH than animals exposed
to 21% oxygen (CK: 4381 ± 823 U/l in 21% and 1956 ± 553 in 18%,
n = 5, P = 0.04; LDH: 1424 ± 210 U/l in 21% and 591 ± 117 in 18%,
n = 5, P b 0.001; Fig. 3).3.2. 24 h-long exposure to 18% oxygen does not activate ERK or AMPK
signalling in the heart
In H9C2 heart embryonic cells, it has been previously shown that
in vitro chronic mild hypoxia activates ERK leading to increase in
SUR2A levels [20]. Here we have tested whether exposure to 18%
oxygen would phosphorylate ERK. Exposure to 18% oxygen did not
have any effect on either ERK1 or ERK2 (signal intensity: ERK1:
46.9 ± 11.0 AU in mice exposed to 21% oxygen and 56.3 ± 3.5 AU
in mice exposed to 18% oxygen, n = 4–5, P = 0.393; ERK2: 90.2 ±
19.6 AU inmice exposed to 18% oxygen and 118.3 ± 4.3 AU in mice ex-
posed to 21% oxygen, n = 4–5, P = 0.158; Fig. 4). The ratio of phospho
vs total ERK was also not affected for both ERK1 (0.18 ± 0.05 for mice
exposed to 21% oxygen and 0.20 ± 0.01 for mice exposed to 18% oxy-
gen, n=4–5, P=0.520; Fig. 4) and ERK2 (0.21±0.05 formice exposed
to 21% oxygen to 0.25 ± 0.01 in mice exposed to 18% oxygen, n = 4–5,
P = 0.291; Fig. 4). Activation of AMPK is known to stimulate trafﬁcking
of KATP channels subunits, including SUR2A [21]. Therefore, we have ex-
amined whether exposure to 18% oxygen phosphorylates AMPK. An in-
crease in both phosphorylated (signal intensity: 67.6 ± 1.6 AU in mice
exposed to 21% oxygen and 76.0 ± 1.6 AU in mice exposed to 18% oxy-
gen, n=4–5, P b 0.001; Fig. 5) and total (signal intensity: 45.9± 1.5 AU
in mice exposed to 21% oxygen and 51.7 ± 1.4 AU in mice exposed to
18% oxygen, n = 4–5, P = 0.03; Fig. 5) AMPK was observed (Fig. 5).
However, the ratio of phospho vs total AMPK was not affected at all
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Fig. 3.Exposure to 18%oxygen increases heart resistance to ischaemia–reperfusion. Bar graphsdepicting size ofmyocardial infarction, CKand LDHconcentration inheart efﬂuent following
ischaemia–reperfusion. Each bar is a mean ± SEM (n = 3–5). *P b 0.05.
713K.S. Mohammed Abdul et al. / Biochimica et Biophysica Acta 1852 (2015) 709–719(1.48 ± 0.07 for mice exposed to 21% oxygen and 1.47 ± 0.04 for mice
exposed to 18% oxygen, n = 4–5, P = 0.958; Fig. 5).
3.3. 24 h-long exposure to 18% oxygen activates PI3K/Akt signalling
pathway
Antibodies targeting phosphorylation of Akt at S473 and T308 were
used as well as an antibody targeting Akt non-selectively to examine
whether exposure to 18% oxygen phosphorylates Akt in the heart.
Exposure to 18% oxygen was associated with phosphorylation of S473
Akt site (signal intensity: 63.8±21.8 AU inmice exposed to 21% oxygen
and 126.7±8.6 AU inmice exposed to 18% oxygen, n=4–5, P=0.022;
Fig. 6; the ratio of phospho S473 vs total Akt was 0.17 ± 0.06 for mice
exposed to 21% oxygen and 0.33 ± 0.02 for mice exposed to 18%
oxygen, n = 4–5, P = 0.024; Fig. 6). On the other hand, exposure of
mice to 18% oxygen did not affect phosphorylation on T308 site (signal
intensity: 54.4 ± 19.5 AU in mice exposed to 21% oxygen and 89.2 ±
11.9 AU in mice exposed to 18% oxygen, n = 4–5, P = 0.142; Fig. 6;
the ratio of phospho T308 vs total Akt was 0.15 ± 0.06 for mice
exposed to 21% oxygen and 0.23 ± 0.03 for mice exposed to 18%
oxygen, n = 4–5, P = 0.157; Fig. 6).
3.4. Phosphorylation of S473 Akt site is responsible for up-regulation of
SUR2A in the heart induced by 24 h-long exposure to 18% oxygen
Akt S473 phosphorylation could have been a process independent
from regulation of SUR2A. In order to ﬁnd out a causal relationship be-
tween phosphorylation of Akt at S473 site and SUR2A, we have treated
animalswith LY294002, an inhibitor of PI3K (22).When treated animals
exposed to 18% oxygen were compared with untreated animals
exposed to 21% oxygen no differences in Akt phosphorylation was
observed regardless of the site (signal intensity: S473Akt: 56.7 ±
22.7 AU in mice exposed to 21% oxygen and 69.3 ± 9.7 AU in mice
exposed to 18% oxygen, n = 3 for each, P = 0.635; T308Akt: 26.8 ±
2.8 AU in mice exposed to 21% oxygen and 30.9 ± 2.3 AU in mice ex-
posed to 18% oxygen, n = 3 for each, P = 0.372; Fig. 7). The ratio of
phospho vs total Act was not changed for both S473 (0.09 ± 0.03 in
untreated mice exposed to 21% oxygen and 0.10 ± 0.01 in treated
mice exposed to 18% oxygen, n = 3, P = 0.653; Fig. 7) and T308
(0.40 ± 0.03 in untreated mice exposed to 21% oxygen and 0.46 ±
0.02 in treated mice exposed to 18% oxygen, n = 3, P = 0.208; Fig. 7)
site.
Western blot did not reveal any difference in signal intensity
between animals exposed to 21% oxygen and those exposed to 18%Fig. 2. Systemic exposure to 18% oxygen regulates levels of NAD+, NADH, lactate, LDH and SU
blood as well as ATP (ATP), lactate (Lactate), LDH, total NAD (NADt), NADH (NADH), NAD+ (N
original Western blots for SUR2A under labelled conditions. Each bar is a mean ± SEM (n= 3oxygen and treated with LY294002 (Fig. 7; signal intensity: 44.5 ±
6.6 AU in untreated mice exposed to 21% oxygen and 46.8 ± 6.8 AU in
treated mice exposed to 18% oxygen, n = 3 for each, P = 0.825).
When untreated and treated mice exposed to 18% oxygen were com-
pared, LY294002-treatment prevented both Akt S473 phosphorylation
and increase in myocardial SUR2A (Fig. 7). In addition, treatment with
LY294002 abolished cardioprotection afforded by 18% oxygen (Fig. 7;
the size of myocardial infarction was 32.4 ± 1.9% in mice exposed to
21% of oxygen, 22.7 ± 1.8% in mice exposed to 18% oxygen and
29.2 ± 1.4% in mice pretreated with LY294002 and exposed to 18%
oxygen, P = 0.0469 when LY294002-treated mice are compared with
18% oxygen-untreated mice and P = 0.426 when they are compared
with 21% oxygen-untreated mice, n = 3 for each).
3.5. Phosphorylation of S473 Akt site is also responsible for up-regulation of
LDH and increased lactate production in the heart induced by 24 h-long
exposure to 18% oxygen
One of the important features of exposure to 18% oxygen was
up-regulation of heart LDH and increased levels of lactate (Fig. 2). If
up-regulation of SUR2A is S473 Akt-dependent and SUR2A expression
is regulated by LDH and lactate, it would be logical to expect that phos-
phorylation of S473 Akt also regulates LDH and lactate levels. Therefore,
we measured levels of LDH and lactate in mice treated with LY294002
and exposed to 18% oxygen. LY294002 prevented increase in lactate
(lactate levels were 0.20 ± 0.00 mmol/l in untreated mice exposed
to 21% and 0.12 ± 0.02 mmol/l in treated mice exposed to 18%,
P b 0.001, n = 4–5; Fig. 8) and LDH (2729.6 ± 201.8 U/l in untreated
mice exposed to 21% and 2936.0 ± 149.1 in treated mice exposed to
18%, n = 4–5, P = 0.434; Fig. 8).
3.6. LDH regulates expression of SUR2A
To test further a relationship between LDH/lactate and SUR2A
expression we have used galloﬂavin and sodium oxamate, inhibitors
of LDH. In rat heart embryonic H9c2 cells, 24 h-long treatment with
galloﬂavin (50 μM) and sodium oxamate (80 mM) signiﬁcantly
decreased levels of SUR2A (Fig. 9; galloﬂavin: signal intensity was
47.9 ± 1.0 AU in the absence and 28.9 ± 1.3 AU in the presence of
galloﬂavin, n = 3, P b 0.001; sodium oxamate: signal intensity was
17.8 ± 1.8 AU in the absence and 10.9 ± 1.7 AU in the presence of sodi-
um oxamate, n = 3, P = 0.049). To determine whether increase in lac-
tate alone is sufﬁcient to up-regulate SUR2A,we have treated H9c2 cells
with sodium lactate (30 mM). This treatment signiﬁcantly increasedR2A in the heart. Bar graphs depicting PO2 (O2), PCO2 (CO2) and haematocrit (HCT) in the
AD+) and SUR2A (SUR2A) in the myocardial tissue; inset in SUR2A bar graph represents
–5). *P b 0.01. AU= arbitrary units.
Fig. 4. Systemic exposure to 18% oxygen does not phosphorylate ERK1/2 in the heart. Original Western blots with phospho-ERK1, phospho-ERK2 and total ERK1 and ERK2 antibodies
applied on extracts from hearts under depicted conditions and corresponding graphs. Each bar is a mean ± SEM (n = 4-5). AU= arbitrary units.
Fig. 5. Systemic exposure to 18% oxygendoes not phosphorylate AMPK in the heart. OriginalWestern blotswith phospho-AMPK and total AMPKantibodies applied on extracts fromhearts
under depicted conditions and corresponding graphs. Each bar is a mean ± SEM (n= 4–5). AU= arbitrary units.
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Fig. 6. Systemic exposure to 18% oxygen phosphorylates S473Akt in the heart. Original Western blots with phospho-S473-Akt, phospho-T308-Akt and total Akt antibodies applied on
extracts from hearts under depicted conditions and corresponding graphs. Each bar is a mean ± SEM (n= 4–5). *P b 0.05. AU= arbitrary units.
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untreated H9c2 cells and 0.10 ± 0.00 mmol/l, n = 3, P = 0.00; Fig. 9),
but it did not affect levels/activity of LDH (2317.7±104.9U/l in untreat-
ed cells and 2279.7 ± 38.9 in cells treated with sodium lactate, n = 3,
P = 0.751; Fig. 9). No difference was observed in SUR2A
levels between untreated cells and cells treated with sodium lactate
(30 mM; Fig. 9; signal intensity was 82.0 ± 9.4 AU in untreated cells
and 76.3 ± 6.3 AU in cells treated with sodium lactate, n = 3, P =
0.638). 193glyM-LDH is amutant form ofmuscle lactate dehydrogenase
(M-LDH) that has lost its catalytic activity that has been shown to have
major effect on LDH activity inH9c2 cells [8]. Infection ofH9c2 cellswith
193glyM-LDH signiﬁcantly increased cellular susceptibility towards
severe metabolic stress induced by DNP (10 mM; Fig. 9; survival of
control cells was 45.6 ± 2.3% and 18.8 ± 4.4% for cells infected with
193glyM-LDH, n = 3–5, P b 0.001).
4. Discussion
Normobaric 18% oxygen corresponds to oxygen tension at ~1200 m
above sea level. When effects of several hours-long hypoxia is studied
in vivo, usually lower concentration of oxygen is applied (typically
6–16%) than the one we applied in the present study [17,23]. In order
to determine whether 18% oxygen induced any sign of hypoxia we
have measured a string of parameters. PO2 in the blood was lower
than those inmice at ambient oxygen, but the difference was not statis-
tically signiﬁcant. ATP levels in the heart were also not changed, which
is probably not entirely surprisingwhen considering thatmicewere ex-
posed to very mild hypoxia. However, NAD+/NADH ratio in the heartdid change and lactate increased. A change in NAD+/NADH ratio is
one of the hallmarks of myocardial response to hypoxia [24] and these
ﬁndings suggest that systemic exposure to 18% oxygen induced hypoxia
in mouse hearts in vivo. An increase in lactate is additional sign of
hypoxia in the heart as lactate is a product of anaerobic glycolysis [23].
Decades ago, it has been suggested that high-altitude residents
have lowermortality rates for ischaemic heart disease [13–15]. Later ex-
periments on animals have demonstrated that exposure to moderate
hypoxia confers cardioprotection [16,17]. It has been suggested
that adaptive metabolic reorganisation, in particular increase in
utilisation of carbohydrates as cardiac fuel substrate (versus fatty
acids) and augmented mitochondrial respiratory capacity mediate
observed cardioprotection [23]. Also, chronic hypoxia is associated
with metabolic gene remodelling [23]. SUR2A is a signiﬁcant regulator
of myocardial resistance to stress whose expression is regulated by
mild hypoxia in vitro [20]. In fact, it has been shown that SUR2A was
particularly sensitive to changes in oxygen tensions as 13% of oxygen
in vitro affected expression exclusively of this protein [20]. In the
present study, systemic exposure to 18% resulted in substantial increase
in SUR2A levels in the heart, which is in agreement with the notion that
SUR2A expression is highly sensitive to hypoxia. It is well established
that increased SUR2A levels confer cardioprotection [12] and our ﬁnd-
ings can explain, at least in part, why residents living at high altitude
would have lower mortality rates for ischaemic heart disease. Size of
myocardial infarction, CK and LDH are well established markers of
myocardial injury [24], and we have measured them to determine
whether exposure to 18% oxygen is cardioprotective. Indeed, exposure
to 18% oxygen decreased the size of myocardial infarction as well as
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Fig. 8. Akt regulates LDH/lactate, which, in turn, regulates SUR2A. LY294002 inhibits increase in LDH and lactate in the heart in response to 18% oxygen. Bar graphs depicting LDH (LDH)
and lactate (Lactate) levels in extracts from hearts under depicted conditions (21% refers to untreatedmice exposed to 21% oxygen and 18% tomice treatedwith LY294002 and exposed to
18% oxygen). Each bar is a mean ± SEM (n = 4–5).
717K.S. Mohammed Abdul et al. / Biochimica et Biophysica Acta 1852 (2015) 709–719amounts of CK and LDH released from the myocardium in response to
ischaemia–reperfusion suggesting an increase in myocardial resistance
to injury. These results ﬁt into the notion that mild hypoxia increases
levels of SUR2A in the heart resulting in cardioprotection. In addition
to SUR2A, we have also found that exposure to 18% oxygen increased
levels of LDH in the heart, which is in agreement with previous studies
showingup-regulation of LDH induced by chronic hypoxia [25]. This can
also explain increased lactate levels in the heart tissue we observed.
In vitro, it has been shown that activation of ERK is themain event in
hypoxia-mediated up-regulation of SUR2A [20]. We have also recently
found that sub-hypoxic drop in oxygen activates ERK to up-regulate
SUR2A [19]. However, in the present study, we have shown that in vivo
exposure to 18% hypoxia did not affect phosphorylation of ERK1/2
meaning that this kinase does not mediate the effect on SUR2A that we
observed. This suggests that different signalling pathway(s) regulate
expression of SUR2A in sub-hypoxic decrease in oxygen tension and
mild hypoxia.
It has been previously demonstrated that phosphorylation of
AMPK and PKB (Akt) mediates cardioprotection. AMPK-mediated
cardioprotection was associated with regulation of sarcolemmal KATP
channel number and activity [21], while phosphorylation of PKB/Akt
was associated with regulation of mitochondrial function [26,27].
None of these kinaseswere associatedwith regulation of SUR2A expres-
sion so far. Here, we have found that exposure to 18% oxygen did not
phosphorylate AMPK, but it phosphorylated Akt. The activation of
PI3K/Akt signalling cascade by hypoxia has been previously reported
[28] and from this prospective phosphorylation of Akt by hypoxia
in vivo was not entirely unexpected. What is interesting is that phos-
phorylation of S473 was observed alone, while T308 site was not phos-
phorylated. Phosphorylation of site T308 was previously associated
with 3-phosphoinositide-dependent protein kinase-1 (PDK1; ref.
[29]), while phosphorylation of the S473 site is a more controversial
issue. It has been suggested that mammalian target of rapamycin
(mTOR) complex 2 (mTORC2) is responsible for S473 phosphorylation
and that this requires assistance of PKCε (epsilon isoform of protein
kinase-C; ref. [30]). PKCε has been already shown to be activated byFig. 7. LY294002 inhibits phosphorylation of S473Akt, increase of SUR2A in the heart and card
phospho-T308-Akt and total Akt antibodies applied on extracts from hearts under depicted c
with LY294002 and exposed to 18% oxygen) and corresponding graphs as well as a graph sho
SEM (n = 3–5). *P b 0.05. AU= arbitrary units.hypoxia in vivo where it acts in a cardioprotective way [17], which is
in agreement with our notion that hypoxia phosphorylates Akt at
S473. A lack of phosphorylation at the T308 site would suggest that
PDK1 is probably not involved in the signalling pathway we observed
here, which is also compatible with our previous study showing
that the primary target of PDK1-mediated cardioprotection are mito-
chondria [26]. A simultaneous phosphorylation of S473 Akt and up-
regulation of SUR2A did not necessarily mean that these two events
are connected. Therefore, to test a causal relationship between Akt
and SUR2A, we have used an inhibitor of PI3K, LY294002 [22]. We
found that this compound inhibited S473 phosphorylation as well as
up-regulation of SUR2A and cardioprotection induced by 18% oxygen
in vivo. This demonstrates a causal relationship between S473Akt
phosphorylation and SUR2A levels.
We had also taken advantage of LY294002 to assess whether
up-regulation of LDH and increase in lactate level has anything to do
with Akt phosphorylation. LY294002 inhibited the effect of 18% oxygen
on LDH and lactate suggesting that 1) activation of PI3K/Akt signalling
cascade is required for up-regulation of LDH and that 2) increased
level of lactate is most likely a consequence of increased level of LDH.
These ﬁndings provided a link between PI3K/Akt and LDH expression.
Taking these into account, the question whether LDH/lactate and
SUR2A are linked naturally arises.
To address this question we have tested whether LDH/lactate could
regulate levels of SUR2A in a different cellular system: rat heart embry-
onic H9c2 cell line. These cells have been usedwith success to study ex-
pression of SUR2A [7–9,31]. We have used sodium oxamate (structural
analogue of pyruvate) and galloﬂavin (a novel highly selective inhibitor
of LDH), two compounds known to inhibit LDH [32,33]. We found that
these inhibitors signiﬁcantly decreased the level of SUR2A in H9c2
cells showing that LDH activity regulates SUR2A levels. Based on these
ﬁndings we supposed that lactate levels controlled by LDH regulate
SUR2A expression. To test this hypothesis we have treated cells with a
concentration of sodium lactate that increased lactate levels without af-
fecting LDH activity. Surprisingly, this treatment did not affect SUR2A
levels suggesting that lactate does not mediate the effect of LDH. Thatioprotection in response to 18% oxygen. Original Western blots with phospho-S473-Akt,
onditions (21% refers to untreated mice exposed to 21% oxygen and 18% to mice treated
wing the size of myocardial infarction under depicted conditions. Each bar is a mean ±
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719K.S. Mohammed Abdul et al. / Biochimica et Biophysica Acta 1852 (2015) 709–719the LDH activity is crucial in cellular response to stress was further con-
ﬁrmed by our ﬁnding that an inactive mutant form of LDH signiﬁcantly
increased sensitivity of H9c2 towards DNP. So, how is it possible that
LDH could regulate levels of SUR2A independently from the lactate
production? Recently, it has been suggested that LDH can bind to DNA
and regulate RNA synthesis in a process that is unrelated to LDH
property to catalyse lactate production [34]. Such effect of LDH could
mediate regulation of SUR2A levels by LDH.
Taking all these together, it is possible to suggest a signalling cascade
that mediates up-regulation of SUR2A in the heart of mice exposed to
18% oxygen in vivo. 18% oxygen activates PI3K/Akt signalling cascade
that up-regulates LDH. Increase in LDH increases level of SUR2A
independently from increased lactate production. This is the ﬁrst
account of SUR2A-mediated regulation by Akt and LDH.
5. Conclusion
In conclusion, this study has shown that mild hypoxia (18%)
up-regulates cardioprotective SUR2A by activating PI3K/Akt signalling
cascade that targets LDH to increase SUR2A independently from its
property to catalyse lactate production.
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